Clinical Trial Update: Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Copper-64 PSMA I&T PET imaging in men with newly diagnosed prostate cancer; study status is active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Copper-64 PSMA I&T (Copper-64 PSMA I&T)

Snippet

Sponsor: Curium US LLC | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING